NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.07
-0.69 (-5.41%)
At close: Mar 6, 2026, 4:00 PM EST
12.39
+0.32 (2.65%)
After-hours: Mar 6, 2026, 4:10 PM EST
NextCure Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 12.69 | 15.72 | 19.71 | 21.71 | 20.57 | |
| Research & Development | 44.92 | 41.49 | 47.93 | 54.2 | 50.19 | |
| Operating Expenses | 57.62 | 57.21 | 67.64 | 75.91 | 70.77 | |
| Operating Income | -57.62 | -57.21 | -67.64 | -75.91 | -70.77 | |
| Interest Expense | - | - | - | - | -0.08 | |
| Interest & Investment Income | - | 4.09 | 4.91 | 1.17 | 1.4 | |
| Other Non Operating Income (Expenses) | 1.77 | - | - | - | - | |
| EBT Excluding Unusual Items | -55.84 | -53.11 | -62.72 | -74.74 | -69.45 | |
| Merger & Restructuring Charges | - | -2.54 | - | - | - | |
| Gain (Loss) on Sale of Investments | - | - | - | 0.01 | 0.06 | |
| Pretax Income | -55.84 | -55.65 | -62.72 | -74.73 | -69.39 | |
| Net Income | -55.84 | -55.65 | -62.72 | -74.73 | -69.39 | |
| Net Income to Common | -55.84 | -55.65 | -62.72 | -74.73 | -69.39 | |
| Shares Outstanding (Basic) | 3 | 2 | 2 | 2 | 2 | |
| Shares Outstanding (Diluted) | 3 | 2 | 2 | 2 | 2 | |
| Shares Change (YoY) | 21.97% | 0.46% | 0.33% | 0.46% | 0.30% | |
| EPS (Basic) | -19.65 | -23.88 | -27.04 | -32.32 | -30.15 | |
| EPS (Diluted) | -19.65 | -23.88 | -27.04 | -32.32 | -30.15 | |
| Free Cash Flow | -49.61 | -41.28 | -53.79 | -56 | -59.64 | |
| Free Cash Flow Per Share | -17.45 | -17.71 | -23.19 | -24.22 | -25.92 | |
| EBITDA | -55.43 | -54.34 | -63.95 | -71.79 | -66.59 | |
| D&A For EBITDA | 2.19 | 2.87 | 3.68 | 4.12 | 4.18 | |
| EBIT | -57.62 | -57.21 | -67.64 | -75.91 | -70.77 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.